Edesa Biotech is trading 6.9% down today at $4.89 as the stock extends a volatility-driven pullback following a sharp rebound earlier in the week.
- The move appears to be a technical correction in a thinly traded stock, with no new company-specific press releases, SEC filings, or clinical updates reported this morning.
- The downward price action diverges from a generally positive backdrop across the broader biotech sector.